{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-22-006866","form_type":"8-K","ticker":"CRVS","cik":"0001626971","company_name":"Corvus Pharmaceuticals, Inc.","filed_at":"2022-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.485924+00:00","generated_at":"2026-06-22T22:43:41.498292+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Corvus Pharma receives Nasdaq delisting notice for bid price below $1.00","bullets":["Nasdaq notified Corvus on Oct 25, 2022 that its stock failed to maintain minimum $1.00 bid price for 30 consecutive business days.","Company has 180 calendar days, until April 24, 2023, to regain compliance by closing at $1.00+ for 10 consecutive days.","If non-compliance persists, Corvus may transfer to Nasdaq Capital Market and seek an additional 180-day grace period.","Corvus may consider a reverse stock split or other options to cure the deficiency but no assurance of success."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-22-006866","json":"https://secwatch.observer/filing/0001171843-22-006866.json","markdown":"https://secwatch.observer/filing/0001171843-22-006866.md","text":"https://secwatch.observer/filing/0001171843-22-006866.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626971/000117184322006866/0001171843-22-006866-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626971/000117184322006866/f8k_102722.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T22:43:41.498292+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6178c26dd8acb62a44b85f8747d00a4254fd14ac","claim":"Corvus Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).","evidence_excerpt":"ule 5450(a)(1) (the “Minimum Bid Price Requirement”). Nasdaq’s written notice does not result in the immediate delisting","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1626971/000117184322006866/0001171843-22-006866-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5450(a)(1), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}